Zenas BioPharma, Inc. (ZBIO)
ZBIO price $28.06 -0.12 -0.43%
- Ticker
- ZBIO
- Price
- $28.06
- Change
- -0.12 -0.43%
- Market cap
- $1.83B
- P/E
- -2.93
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 47
Zenas BioPharma, Inc. functions as a clinical-stage biopharmaceutical firm, concentrating on the creation and market introduction of innovative, immunology-based treatments. The company's primary investigational therapy is obexelimab, a distinctive bifunctional monoclonal antibody intended to address multiple diseases such as immunoglobulin G4-related disease, multiple sclerosis, systemic lupus erythematosus, and…